Optimistic IBS Treatment Pipeline Spurring Positive Market Growth
A number of pharmaceutical companies involved in developing IBS treatment options are in the late-stage pipeline are expected to emerge in the market between now and 2019. This will increase the consumption of medicines and propel the growth of the market. The drugs that are to be launched are expected to cater to the huge…
